Navidea Biopharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference – Chief Business Officer to Provide Business and Development Program Updates –
Press Release: Navidea Biopharmaceuticals, Inc. – 2 hours 27 minutes ago
DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents, today announced that Dr. Thomas Tulip, Executive Vice President and Chief Business Officer, will participate at the Jeffries 2012 Global Healthcare Conference on June 4-7 at the Grand Hyatt in New York City. Dr. Tulip will provide an update of the Company and its development programs on Wednesday, June 6, 2012 at 4:30 PM EDT. Investors and the public are invited to listen to a live webcast of Dr. Tulip’s presentation at http://wsw.com/webcast/jeff68/navb/. Following the conference, the webcast will be archived for approximately 30 days.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.